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Abstract: We investigated temporal trends of codon usage changes for different host species to
determine their importance in Zika virus (ZIKV) evolution. Viral spillover resulting from the potential
of codon adaptation to host genome was also assessed for the African genotype ZIKV in comparison
to the Asian genotype. To improve our understanding on its zoonotic maintenance, we evaluated
in vitro the biological properties of the African genotype ZIKV in vertebrate and mosquito cell lines.
Analyses were performed in comparison to Yellow fever virus (YFV). Despite significantly lower
codon adaptation index trends than YFV, ZIKV showed evident codon adaptation to vertebrate
hosts, particularly for the green African monkey Chlorocebus aethiops. PCA and CAI analyses at the
individual ZIKV gene level for both human and Aedes aegypti indicated a clear distinction between the
two genotypes. African ZIKV isolates showed higher virulence in mosquito cells than in vertebrate
cells. Their higher replication in mosquito cells than African YFV confirmed the role of mosquitoes
in the natural maintenance of the African genotype ZIKV. An analysis of individual strain growth
characteristics indicated that the widely used reference strain MR766 replicates poorly in comparison
to African ZIKV isolates. The recombinant African Zika virus strain ArD128000*E/NS5 may be a good
model to include in studies on the mechanism of host tropism, as it cannot replicate in the tested
vertebrate cell line.
Keywords: African genotype Zika virus; codon adaption dynamics; biological characteristics
1. Introduction
Zika virus (ZIKV) is a mosquito-borne Flavivirus belonging to the Flaviviridae family and the
Spondweni serocomplex. ZIKV was first isolated in 1947 in Uganda from a febrile sentinel rhesus
monkey during a Yellow fever virus (YFV) study [1]. Its natural transmission cycle involves mainly
mosquitoes of the Aedes genus and monkeys [2–6], while human infections are accidental and generally
asymptomatic. However, in clinical pictures of human infection, the Zika fever (ZF) ranges from a febrile
syndrome associated with fever, headache, arthralgia, myalgia, conjunctivitis and cutaneous rash to
severe neurological symptoms such as Guillain-Barré syndrome and microcephaly in newborns [7–10].
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Overall, sexual intercourse, perinatal infection and blood transfusion have been reported as potential
routes of direct transmission of ZIKV among humans [11–13].
The ZIKV genome consists of a linear, single-stranded, positive sense RNA of 10.794 kilobases
(Kb) in length. Like other members of the flavivirus genus, the polyprotein of ZIKV is flanked by
noncoding regions (5′ and 3′NCR) and encodes for three structural proteins (5′-C-prM-E-3′) and
seven nonstructural proteins (5′-NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5-3′). The envelope (E) and the
RNA polymerase (NS5) are major viral proteins mediating binding and membrane fusion and viral
replication, respectively [14–16]. ZIKV is associated with a large genetic diversity clustered in three
lineages (East African, West African and Asian), and the ZIKV genome has been shown to be subject to
recombination and N-glycosylation in nature [17].
Despite serological evidence and entomological data demonstrating ZIKV circulation from 1950s
to 1990s, ZIKV remained limited to a sylvatic cycle in equatorial regions of East and West Africa and
South-East Asia, with few sporadic human cases [1,18–26]. A ZIKV outbreak in humans occurred in
the Yap States of the Federal States of Micronesia in 2007 [27,28]. Subsequently, ZIKV infections were
reported in Cambodia and French Polynesia in 2010 and 2013, respectively, and spread to seventy four
countries worldwide [29,30]. Since 2013, ZIKV has shown a high prevalence in the Americas and was
responsible of a large epidemic in 2015 with Brazil as the epicenter [30–33].
Since the replication cycle of viruses is solely dependent on host translational machinery, efficient
viral replication in a host species of usually different genetic background requires a certain degree of
genetic adaptation. Thus, mutational and selection pressures can result in adaptation to hosts [34,35].
The Codon Adaptation Index (CAI) is a measure of the synonymous codon usage bias, allowing
comparisons of codon usage preferences in different organisms and assessing how well the codon
preferences of a virus matches that of a reservoir host or vector [36–38].
Despite several entomological isolations and sporadic human cases reported in different
countries in Africa [18,22,39–41], ZF outbreaks in humans have been mostly attributed to the Asian
genotype [27–33]. This observation raises the question of whether the adaptation to humans of the
African genotype differs from that of Asian genotype. The low public health impact reported for the
African genotype ZIKV could be associated with its intrinsic properties. Investigation of the biological
and genetic characteristics of African ZIKV strains could improve our understanding of their zoonotic
maintenance. Here, we describe an analysis of the codon usage of the African genotype in comparison
to the Asian genotype. We also analyze in vitro the biological properties of six ZIKV strains circulating
in Africa in mosquito and vertebrate cells. Since ZIKV was first isolated during a Yellow fever disease
investigation [1,21,40], and these two viruses share the main vector (Aedes aegypti) [2], all analyses and
experiments were performed in comparison to YFV, which has a long history of infection in humans
and is still a major public health problem, especially in West Africa, where it circulates almost every
year [42].
2. Materials and Methods
2.1. Sequence Datasets Analyzed
Nucleotide coding sequences from isolates of ZIKV [n = 376 including sequences from African
(n = 20) and Asian (n = 356) genotypes], YFV (n = 51) and tobacco mosaic virus (TMV) (n = 68) that
had information on year and place of isolation and representing all data available to date on Genbank
(www.ncbi.nlm.nih.gov/genbank/) were downloaded and used in this study. The complete coding
sequences were aligned and curated using Muscle algorithm (http://www.drive5.com/muscle/) within
the Unipro UGENE software (http://ugene.net/download.html) [43].
2.2. Codon Usage Tables
In order to calculate the CAI for the coding regions of the TMV, YFV and ZIKV viruses, we used
codon usage tables provided by the CoCoPUTs platform [44,45] for vertebrate hosts including
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Homo sapiens, Macaca mulatta, Erythrocebus patas and Chlorocebus aethiops, and invertebrate vectors
including Aedes aegypti, Aedes albopictus and Culex pipiens (Table 1).










Homo sapiens Vertebrate CoCoPUTs 11 June 2019 119846 78581299 RefSeq
Macaca
mulatta Vertebrate CoCoPUTs 20 July 2020 67214 46960666 RefSeq
Erythrocebus
patas Vertebrate CoCoPUTs 20 July 2020 165 47999 GenBank
Chlorocebus
aethiops Vertebrate CoCoPUTs 20 July 2020 621 183383 GenBank
Aedes aegypti Invertebrate CoCoPUTs 29 May 2019 28043 20013993 RefSeq
Aedes
albopictus Invertebrate CoCoPUTs 20 July 2020 37335 22045256 RefSeq
Culex pipiens Invertebrate CoCoPUTs 20 July 2020 248 52907 GenBank
2.3. Codon Usage Biases Analysis of Viral Coding Genes
We applied the calculation of the CAI value using a frequency table for vertebrate and invertebrate
genes from the CoCoPUTs platform (Table 1) [44,45]. The CAI values were calculated to measure the
synonymous codon usage bias using the CAIcal program [46]. To evaluate the statistical support of the
CAI values, we defined a threshold value or expected CAI (e-CAI) [47] by generating random sequences
with similar GC content, amino acid composition and sequence length to each query sequence (TMV,
YFV and ZIKV). CAI values above the e-CAI were interpreted as statistically significant, meaning that
codon similarity arose from codon preferences, rather than from internal biases [47].
2.4. Adaptation Levels to Host Genome
In order to assess the adaptation level of the African ZIKV genotype to invertebrate and vertebrates,
codon usage of its sequences (n = 20) was then analyzed in comparison to the Asian genotype ZIKV
(n = 356). Sequences of YFV (n = 51) and TMV (n = 68) were used as positive and negative controls,
for adaptation and no adaptation to the human genome, respectively. We also did CAI analyses
for each viral coding region using both A. aegypti and H. sapiens codon usage tables. Additionally,
a principal component analysis to verify clustering patterns according to viral genotypes was performed
considering the different genomic regions of the virus.
2.5. In Vitro Replication Kinetics of African Zika Virus Strains
2.5.1. Samples
The samples used in this study were provided by the WHO Collaborating Centre for Arboviruses
and Hemorrhagic Fevers Reference and Research located at the Institut Pasteur de Dakar in Senegal,
and were obtained during a routine surveillance program for multiple mosquito-borne viruses
conducted for over 50 years [48]. Strains with evidence of recombination and/or presenting motifs of
N-glycosylation on the E protein were included in this study in order to assess the impact of these
mechanisms on ZIKV African genotype growth (Table 2).
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Table 2. Zika virus strains used in this study.










Motif (Ng) Acc. Numbers
ArD128000*E/NS5
Aedes
luteocephalus Senegal 1997 Nigerian 4 2.5 × 10
12 N-D-T KF383117
ArD132912 Aedes dalzieli Senegal 1998 Nigerian 3 1.75 × 107 N-D-I
KF383021,
KF383096
ArD157995*E/NS5 Aedes dalzieli Senegal 2001 Nigerian 4 1.75 × 105 N-D-I KF383118
ArD165522 Aedes vittatus Senegal 2002 Nigerian 3 3.5 × 107 N-D-I
KF383029,
KF383090
MR766 Macaca mulatta Uganda 1947 Ugandan 5 1.5 × 109 —– KX421193
HD78788*E Homo sapiens Senegal 1991 Nigerian 5 1.25 × 108 N-D-T
KF383039,
KF383084
*E: Recombinant strain, breakpoints on Envelope (E); *E/NS5: Recombinant strain, breakpoints on Envelope (E) and polymerase (NS5) proteins (30); Ng: N-glycosylation site at Asn-154 of
the Envelope protein (Asn-X-Thr) (25, 30).; Asn: Asparagine (N), Asp: Asparatate (D), Ile: Isoleucine (I), Thr: Threonine (T), “—–”:Complete deletion.
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2.5.2. Viral Stocks Preparation
Aedes pseudoscutellaris clone 61 (Ap61) continuous cell lines were inoculated with strains used in
this study and incubated at 28 ◦C without CO2 until a cytopathic effect (CPE) was observable. Infection
status was assessed by indirect immunofluorescence assay (IFA) as previously described [49], and virus
titers were determined by plaque assay, as previously described [50], using porcine kidney stable cells
(PS cells; American Type Culture Collection, Manassas, VA). The supernatants of infected cells were
frozen at −80 ◦C and used as viral stocks for growth kinetics experiments.
2.5.3. Growth Kinetics
An amount of 2.4 × 105 Ap61 or African green monkey kidney epithelial cells (Vero cells;
Cercopithecus aethiops; Sigma Aldrich, France) were seeded into each well in a volume of 400 µL of
appropriate medium [51]. In addition, viral stocks were standardized to the number of plaques forming
units per milliliter (PFU/mL), as in previous studies [42,51,52], and cells in each well were infected
with 2.4 × 103 plaque-forming units (PFU) of virus in 400 µL of medium, resulting in a multiplicity of
infection (MOI) of 0.01. Experiments were conducted in 12-well plates using one plate per virus strain
with one uninfected well as a negative control. Plates with infected Ap61 and Vero cells were incubated
at 28 ◦C without CO2, and at 37 ◦C with CO2, respectively. After an incubation time of 4 h, the medium
was collected and replaced with 2 mL of new medium to set a start point for the growth kinetics (T0).
At different time points corresponding to 22, 28, 50, 75, 99, 124, and 146 h post infection (hpi),
one well per plate was harvested and the supernatants were collected and frozen at −80 ◦C in small
aliquots until use. Cells were washed once with phosphate-buffered saline (PBS) and then collected
in 500 µL PBS. A volume of 20 µL of cell suspension was dried on a glass slide for a subsequent
immunofluorescence assay [50] to measure viral antigens production; the remaining cell suspensions
were frozen at −80 ◦C. Then, RNA was extracted from cell fractions, and supernatants and copy
numbers of the genome were quantified using a real-time reverse transcriptase quantitative polymerase
chain reaction (RT-qPCR) and a standard equation previously described for ZIKV quantification [53].
Finally, infectious viral particles were measured in supernatants by plaque assay [50]. The growth
kinetics experiments were performed three times on each cell type.
2.5.4. Comparison with Data from In Vitro Growth of YFV
Data of genome production obtained on Ap61 cells during these experiments with ZIKV were also
compared to those we previously obtained for YFV in the same conditions with the same MOI as for
ZIKV [42] to better understand the zoonotic maintenance of ZIKV. Information about the YFV strains
used in the analyses of growth behavior in mosquito cells was provided by the Institut Pasteur de
Dakar, WHO Collaborating Center for arboviruses and viral hemorrhagic viruses (CRORA) in Senegal;
this data is gathered in Table 3.
Table 3. Yellow fever strains used in analyses of growth behavior.





333 Aedes aegypti ArD 114896 Senegal 1995 3 JX898871
307 Aedesafricanus DakArAmt7 Côte d’Ivoire 1973 1 JX898869
357 Aedes furcifer ArD 156468 Senegal 2001 4 JX898876
345 Aedes furcifer ArD 149214 Senegal 2000 5 JX898873
314 Aedes furcifer ArD 121040 Senegal 1996 6 JX898870
Asibi Homo sapiens Ghana 1927 KF769016
17D Homo sapiens 17D RKI #142/94/1 JN628279
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2.6. Data Analysis
Perl and R scripts were used to analyze codon usage data in this study, and are available from the
authors upon request. In addition, the percentage of immunofluorescence, the logarithm of RNA copy
number and the logarithm of viral titers are supposed to be normally distributed, and a Student’s test
was used to analyze differences between virus strains.
3. Results
3.1. Temporal Trends in CAI Changes to Host Genes
We explored possible changes in CAI over time for YFV and ZIKV using human, monkey and
arthropod vector codon usage tables. Both had large numbers of available, serially stamped, complete
polyprotein sequences, allowing us to investigate the temporal trends of ZIKV CAI, and to compare
differences in the CAI of YFV strains (Figure 1).
YFV demonstrated codon adaptation for both vectors and mammalian hosts across all sampled
strains, and the eight CAI trend lines were highly correlated (Spearman’s rank correlation test, p-values
< 2.2 × 10−16, rho ranging from 0.988 to 0.999). YFV CAI was significantly higher for mammalian than
that for vector codon usage (Wilcoxon rank sum test, p-values < 2.2 × 10−16). In addition, YFV CAI
was significantly higher for monkeys than for human codon usage (Wilcoxon rank sum test, p-values
< 0.00248), and could be associated with the important role of these monkey species in enzootic
transmission of YFV. We also observed significant CAI differences between mosquito vectors with
higher CAI for Aedes aegypti than for Aedes albopictus and Culex pipiens codon usage (Wilcoxon rank sum
test, p-values < 0.0004), indirectly confirming Aedes aegypti as the main vector for YFV. No significant
differences of YFV CAI were observed for HKgs and AVgs (Wilcoxon rank sum test, p-value = 0.82),
or between monkey species (Wilcoxon rank sum test, p-values ranging from 0.461 to 0.560) (Figure 1A).
Similar to YFV, a positive correlation was observed in ZIKV codon adaptation to all eight trend
lines (Spearman’s rank correlation test, p-values < 2.2 × 10−16, rho ranging from 0.953 to 0.996).
However, ZIKV showed a higher CAI towards HKgs than to AVgs (Wilcoxon rank sum test, p-value <
2.2 × 10−16). This effect could have an important impact on the intrinsic biological characteristics of
ZIKV during human infection, such as the level of immune response induction.
Across all eight codon usage tables, ZIKV had the highest CAI to Chlorocebus aethiops (green
African monkey) codon usage (Wilcoxon rank sum test, p-value < 2.2 × 10−16). CAI values were
significantly higher for Aedes aegypti, the main vector for ZIKV (Wilcoxon rank sum test, p-values
< 2.2 × 10−16), and below 1 for Aedes albopictus and Culex pipiens, indicating no evidence for codon
adaptation for these mosquito species (Figure 1B).
On average, ZIKV strains displayed 0.25–0.40 lower CAI values than the YFV strains for all eight
codon usage tables tested. In addition, temporal trends have exhibited a variation in ZIKV population
size during the last decade, while YFV showed a large population size before the 2000s (Figure 1A,B).
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Figure 1. CAI changes to host genes over time for (A) YFV and (B) ZIKV. For each codon usage
table, the CAI was normalized by length, percentage of GC and amino acid content for each dataset.
The area of the plot points reflects the density of sequences at a specific time point (year). A CAI trend
line above 1 (dashed black line) shows evidence of codon adaptation to the host. A trend line was
generated using LOESS, a nonparametric regression method, with a 0.95 confidence interval (shaded
areas). Data obtained from codon usage tables are colored in dark grey for Aedes aegypti, in brown for
Aedes albopictus, in green for Chlorocebus aethiops, in grey for Culex pipiens, in blue for Erythrocebus patas,
in orange for human housekeeping genes (HKgs), in red for highly expressed human antiviral genes
(AVgs) and in purple for Macaca mulatta.
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3.2. CAI Values of Host Genes
The results of the calculation of the CAI values for different hosts, including vertebrates and
invertebrates, indicated that ZIKV and YFV had a similar distribution of CAI values for invertebrate
vectors and vertebrates, but that ZIKV had slightly lower CAI values than YFV. As expected, both had
higher CAI values for all hosts when compared to TMV. Among vertebrate hosts, Homo sapiens
presented the highest values, considering the distribution of CAI values for both arboviruses tested.
For invertebrates, Aedes aegypti, followed by Aedes albopictus, which are considered to be important
vectors for the transmission of arboviruses to vertebrates (Figure 2), had the highest CAI values.
Figure 2. CAI value comparison between ZIKV and YFV to (A) vertebrate hosts and (B) invertebrate
vectors. TMV was included as a negative control, since it is not expected to have a codon bias to
animals. Data obtained for TMV, YFV and ZIKV are colored in red, green and blue, respectively.
A principal component analysis on hosts with the highest CAI values (H. sapiens and A. aegypti)
indicated a grouping of the two ZIKV genotypes in different groups. This suggested that each genotype
may interact with distinct host species (Figure 3). A CAI analysis at the individual ZIKV gene level
and/or genomic regions indicated clear differences between the two genotypes. The most evident
distinction was observed on the ZIKV coding region for the NS1 protein, which had CAI values higher
in the Asian compared to the African genotype for both human and mosquito (Figures 4 and 5).
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Figure 3. Principal component analysis comparing the CAI values to the Homo sapiens and to the Aedes
aegypti mosquito, comparing between African (red dots) and Asian (blue dots) Zika virus genotypes.
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Figure 4. Comparison of the CAI values at the individual ZIKV gene/genomic region levels between
the African and Asian ZIKV genotypes to the Aedes aegypti mosquito, the main urban ZIKV vector.
Data obtained for the African and Asian ZIKV genotypes are colored in light orange and dark
orange, respectively.
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Figure 5. CAI values for the African and Asian ZIKV genotypes to Homo sapiens at the individual ZIKV
gene/genomic region levels. Data obtained for the African and Asian ZIKV genotypes are colored in
light blue and sky blue, respectively.
3.3. In Vitro Growth Kinetics of African ZIKV Strains
In order to understand the biology of the African genotype ZIKV in mosquito vector and vertebrate
hosts, the replication kinetics of six African genotype ZIKV strains were determined in AP61 and Vero
cells. Infection, viral proliferation and virulence in each cell type were measured by three different
tests over a time period of 146 hpi.
We observed that African ZIKV strains had distinct growth dynamics in each cell line. In vertebrate
cells, the strains ArD157995*E/NS5 and ArD165522 presented a significantly higher production of
infectious particles than other African strains from 22 hpi to 50 hpi (p-values ranging from 4.25 × 10−12
to 0.0001). The strain ArD132912 and the human strain HD78788*E showed a production of infectious
particles from 75 hpi while the reference monkey strain MR766 released infectious particles very late,
i.e., from 99 hpi. Strikingly, we did not detect any infectious particles for the strain ArD128000*E/NS5
isolated from a mosquito over a period of 146 hpi (p-values ranging from 9.26 × 10−10 to 4.79 × 10−1).
However, no significant difference was found between other African ZIKV strains from 75 hpi to 146 hpi
(Figure 6A). The highest replication after 146 hpi was recorded for strains ArD157995*E/NS5, ArD165522
and ArD132912, which showed similar growth dynamics. Significantly reduced replication efficiency
was observed for the reference strain MR766, reduced replication for the human strain HD78788*E
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and the mosquito strain ArD128000*E/NS5 (Figure 6C,E). The strains ArD157995*E/NS5, ArD165522,
ArD132912 and ArD128000*E/NS5 showed a higher efficiency in the production of viral antigens,
while the reference monkey strain MR766 and the human strain HD78788*E were characterized by
significant lower production of viral proteins at 124 hpi and 146 hpi (p-values ranging from 7.32 × 10−15
to 0.0001) (Figure 6G).
Figure 6. Growth kinetics of African Zika virus strains. The strain label is in reference to the strains
in Table 2. Figure 6A–H show the number of infectious viral particles (A and B) (log10 of PFU/mL),
the amount of viral RNA equivalents isolated from supernatants (C and D) and cell fractions (E and F)
(log10 of RNA copy number), and the percentage (%) of immunofluorescence of viral antigen production
(G and H) over a time period of 146 h post infection (hpi). The experiments were performed using
the vertebrate cell line Vero (top row) and the mosquito cell line Ap61 (bottom row). Cells were
infected with the human strain HD78788*E, the reference monkey strain MR766 and the mosquito
strains ArD165522, ArD132912, ArD157995*E/NS5, ArD128000*E/NS5 colored in purple, brown, green,
blue, red and black, respectively. The error bars indicate the range in values of three independent
experiments performed using a multiplicity of infection (MOI) of 0.01.
In mosquito cells, the mosquito strains ArD165522, ArD132912, ArD157995*E/NS5 and
ArD128000*E/NS5 displayed higher infectious particle production, while the reference monkey strain
MR766 and the human strain HD78788*E released significantly reduced amounts of infectious particles
from 124 hpi to 146 hpi (p-values ranging from 3.75 × 10−8 to 0.011) (Figure 6B). More efficient genome
replication was also recorded for the mosquito strains ArD165522, ArD132912, ArD157995*E/NS5 and
ArD128000*E/NS5, while the vertebrate strains MR766 and strain HD78788*E replicated much less over
146 hpi (p-values ranging from 6.19 × 10−9 to 0.0001) (Figure 6D,F). Similar differences were also
observed for viral antigens production, in which the reference monkey strain MR766 and the human
strain HD78788*E showed also lower significant rates than the other ZIKV strains from 124 hpi to
146 hpi (p-values ranging from 9.44 × 10−7 to 1.13 × 10−1) (Figure 6H).
Furthermore, cell line-specific culture differences were observed among African ZIKV strains.
Despite quiet similar quantities of viral particles being released into the supernatants by each strain
in both cell lines, African ZIKV strains produced up to 4 Log10 more infectious viral particles in
mosquito cells than in vertebrate cells (Figure 6A,B); this indicates differing replication efficiencies
in both cell lines or even incomplete replication (Figure 6A–D). For example, infectious particles for
the strain ArD128000*E/NS5 were not detected in supernatants from the vertebrate cells over a time
period of 146 hpi, while the titer of infectious particles (PFU/mL) increased significantly in mosquito
cell supernatants (p-values ranging from 2.63 × 10−12 to 0.035) (Figure 6A,B).
Cell-specific replication differences were obvious for strain ArD165522, which showed a significant
decrease at harvesting times 22 hpi and 28 hpi in cell fractions and supernatants from mosquito cells,
respectively, while it presented high replication rates in the vertebrate cell line during the corresponding
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time points (p-values ranging from 3.75 × 10−10 to 0.027). In addition, the human strain HD78788*E
released fewer RNA copies into supernatants from mosquito cells over 146 hpi, while we found a
significantly higher genome copy number in supernatants from vertebrate cells (p-values ranging from
9.26 × 10−10 to 4.79 × 10−3) (Figure 6C–F). Significantly lower profiles of viral antigen production were
also observed for the human strain HD78788*E and the monkey strain MR766 in both cell lines when
compared to the ZIKV strains ArD165522, ArD132912 and ArD157995*E/NS5 (p-values ranging from
7.32 × 10−15 to 0.002) and the strain ArD128000*E/NS5, which showed a significant increase in viral
antigen production in both cell lines from 99 hpi to 146 hpi (p-values ranging from 2.51 × 10−11 to
6.08 × 10−4) (Figure 6G,H).
In summary, the African ZIKV strains exhibited distinct growth characteristics in each cell line,
and especially in the mosquito cell line. These differences seem to be associated with their host species
origin, as the human strain HD78788*E and the monkey strain MR766 were more cell-specific; both
replicated more abundantly in vertebrate cells (Figure 6A–H), while the mosquito strains ArD165522,
ArD132912, ArD157995*E/NS5 and ArD128000*E/NS5 displayed a more efficient growth in mosquito cells
regarding the production of infectious particles (Figure 6A,B).
Among recombinant ZIKV strains, we observed different profiles. The E and NS5 recombinant
strain ArD157995*E/NS5 replicated more efficiently in both vertebrate and mosquito cell lines. The E and
NS5 recombinant strain ArD128000*E/NS5 exhibited an intermediate replication profile in both cell lines,
while the E recombinant strain HD78788*E presented much lower growth dynamics, particularly in
mosquito cells (p-values ranging from 1.59 × 10−13 to 0.019) (Figure 6A–H). These different replication
profiles may be associated with recombination in the NS5 protein or the simultaneous presence of
recombination in both the E and NS5 proteins, since strains presenting these changes replicated more
abundantly than the E recombinant strain HD78788*E. However, the replication levels of recombinant
strains were not significantly distinct from those of nonrecombinant strains, considering the presence
of profiles with more or less efficient replication in both groups.
Interestingly, the strains ArD165522, ArD132912 and ArD157995*E/NS5, presenting the
N-glycosylation motif NDI at Asparagine 154 of the E protein, showed more efficient growth replication
than strains ArD128000*E/NS5 and HD78788*E with NDT motif or the strain MR766, which showed
complete deletion of that motif (p-values ranging from 3.11 × 10−10 to 0.001). This effect was more
marked in the vertebrate cell line, and showed that N-glycosylation on the E protein can play a major
role in changes during growth of African ZIKV strains (Figure 6A–H).
Finally, we estimated the replication efficiency by finding the ratios of the number of plaque
forming units divided by the total number of particles released in the supernatants (PFU/mL/Particles)
from each time point for each strain in each cell line. We found significant differences in replication
efficiency with much higher and increasing ratios over 146 hpi observed in mosquito cells (p-values
ranging from 6.32 × 10−16 to 0.0013) (Figure 7A,B). African ZIKV strains produced more infectious
viral particles in mosquito cells than in vertebrate cells. This effect was very pronounced for the
recombinant strain ArD128000*E/NS5, which produced no infectious particles at all in Vero cells over
146 hpi (Figure 7A,B). Reference monkey strain MR766 was shown to be the least efficient of all the
ZIKV strains tested in both cell lines.
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Figure 7. Ratios of the number of plaque forming units of African Zika virus divided by the total number
of particles released in the supernatants (PFU/mL/Particles) in vertebrate cells Vero (A) and mosquito
cells Ap61 (B) cell lines. The strain label is in reference to the strains in Table 2. Figure 4A,B shows the
replication efficiency for each strain in each cell line (A and B) over a time period of 146 h post infection
(hpi). Ratios for the human strain HD78788*E are colored in green, the reference monkey strain MR766
is represented in dark gray line and the mosquito strains ArD165522, ArD132912, ArD157995*E/NS5 and
ArD128000*E/NS5 are highlighted in brown, orange, light blue and black, respectively.
3.4. Replication Growth of African YFV
Since YFV and ZIKV share the same main vector, i.e., Aedes aegyti, their growth behaviors were
compared in mosquito AP61 cells.
The growth dynamics of African YFV showed that strains 307, 357, 345 and 314 (belonging to
lineages 1, 4, 5 and 6, respectively) exhibited high growth efficiency regarding the number of RNA
copies and infectious particles produced in mosquito cells. The reference wild-type strain Asibi and
the attenuated vaccine strain 17D replicated less efficiently, while strain 333 (lineage 3) displayed the
lowest replication efficiency (Figure 8A–C).
Figure 8. Replication growth kinetics of African Yellow Fever virus on mosquito cells (Ap61).
Figure 8A–C show the number of infectious viral particles (A) (log10 of PFU/mL), the amount of viral
genome copies quantified from supernatants (B) and cells (C) (Log10 of RNA copy number) over
a time period of 146 h post infection (hpi). The strain label is in reference to the strains in Table 3.
Data obtained with the reference wild-type strain Asibi are colored in light blue and the curves in
red, brown, purple, green, dark blue and orange represent strains 333, 17D, 307, 314, 345 and 357,
respectively. The error bars indicate the range in values of three independent experiments performed
using a multiplicity of infection (MOI) of 0.01.
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In comparison to YFV strains, the growth of African ZIKV strains in mosquito cells was much
slower, but with the exception of the human strain HD78788*E, all African ZIKV strains replicated more
abundantly (from 2 to 6Log10) than YFV strains and produced significantly more infectious particles
in cell supernatants (p-values ranging from 5.02 × 10−6 to 0.001) (Figure 6B–F and Figure 8A–C). These
results suggest a high-titer virus production for the African genotype ZIKV in Aedes mosquito cells,
which could play an important role in its natural maintenance.
4. Discussion
As seen for YFV and West Nile virus (WNV), first isolated in Africa, ZIKV is another flavivirus
which spread from Africa to other continents [2,17]. The genetic diversity and broad host range of
ZIKV [54] might have contributed to its extensive dissemination, and the A188V substitution in the
NS1 protein of Asian ZIKV strain may be key to ZIKV spread from southeastern Asia across the Pacific
islands to the Americas [55,56]. Its natural transmission cycle mainly involves monkeys, arboreal
mosquitoes and, occasionally, humans.
The evolutionary adjustment of viruses to hosts through codon usage adaptation may reveal the
role of host in natural maintenance of particular viruses.
Temporal analyses of CAI are informative in better identifying time points, which were marked
by advantageous nonsynonymous changes in different hosts. Despite low CAI changes observed in its
evolution, ZIKV shows slow evolutionary dynamics just like those of YFV [17,36,57,58]. Nevertheless,
this slow evolution dynamic might be helpful for efficient replication of RNA viruses in the host,
as more than one codon can be used for the same amino acid [56,59,60]. The significant lower CAI to
AVgs than to HKgs could be linked to the ability of ZIKV to evade the immune system, in addition
to inhibiting IFN production, as previously reported [61]. In addition, the higher CAI of ZIKV to
Chlorocebus aethiops (green African monkey) is not surprising, because several monkey species have
been identified as primary reservoirs of ZIKV [62], and therefore this monkey species could be involved
in sylvatic ZIKV transmission in Africa. However, the recent detection of ZIKV in neotropical primates
(Sapajus libidinosus) highlights the possibility that other host species could be involved in a sustained
sylvatic cycle in the Americas [63], but perhaps also in Africa, and their role in ZIKV maintenance
needs to be understood.
The abrupt variation observed in ZIKV population sizes over time could be correlated to the
rapid increase of available sequencing data [64] and to the recent wide distribution of ZIKV from the
Pacific Islands to the Americas [30–33]. The high NS1 CAI values of the Asian genotype for the human
genome confirmed in this study were associated with the Asian genotype ZIKV for humans [65].
The lower CAI values obtained for the Aedes aegypti mosquito vector could explain the low
competence for ZIKV for Aedes aegypti in the Americas [66] or the insignificant ZIKV transmission by
Aedes aegypti in Africa, where it is transmitted by several other Aedes spp. mosquitoes, such as Aedes
vittatus and Aedes luteocephalus [6]; this raises the question of the main Aedes vector for ZIKV in Africa.
Despite multiple isolations from mosquito populations and serological evidence of ZIKV infection
in Africa, a major outbreak in humans attributed to the African genotype ZIKV has not yet been
documented. Codon bias is a common mechanism across the genomes of several organisms and plays
a major role in their evolution. The significant ZIKV adaptation to the genome of monkeys could lead
to possible spillover of the African genotype ZIKV to other vertebrates such as humans, as exhibited by
the high CAI for the human genome, which is actually already higher than the CAI of Asian genotype
ZIKV. This clearly shows that the African genotype ZIKV also has the potential to efficiently replicate
in humans. This is particularly true for the CAI for the E and NS5 proteins [65], which have a major
role in flaviviruses replication and virulence [17].
African genotype ZIKV presents two major clades, which have previously experienced probable
recombination and glycosylation mechanisms in their natural cycle [17,28]. To better understand its
biology in mosquito vectors and vertebrate hosts and assess the effect of these evolutionary mechanisms
on its fitness, the in vitro phenotypical behavior of African ZIKV strains was analyzed over a 146 hpi
Viruses 2020, 12, 1306 16 of 22
period. Thus, infection, viral proliferation and virulence in each cell type were assessed using RT-qPCR
of the lysed cell fraction to measure genome replication, RT-qPCR of the supernatant fraction to detect
genome replication dynamics (i.e., total number of particle released), plaque assays to determine the
amount of infectious viral particles (PFU/mL) from the supernatant fraction, and immunofluorescence
staining of the cells to estimate efficiency in viral antigen production.
While some differences were previously reported between African and Asian ZIKV strains [66–70],
our study focuses on phenotypic differences between African ZIKV strains by characterizing their
growth behaviors in two distinct cell lines. The observed high-titer virus production in mosquito
cells and significantly reduced levels in vertebrate cells may reflect ZIKV maintenance in African
transmission cycles.
The replication levels of African ZIKV strains isolated from mosquitoes in the vertebrate cell line
confirms that these isolates are able to efficiently infect and replicate in vertebrate cells, as, for example,
reported for neuronal cells [70,71]. However, the lower replication efficiency in the vertebrate cell line
might contribute to the inability of African genotype ZIKV to cause severe pathogenicity in vertebrates
such as humans.
Indeed, the African genotype ZIKV has been shown to induce less pathogenicity in human cells
than the epidemic Asian genotype ZIKV, which shows long-term persistence, more consistent with
clinical manifestations [72–74]. The reduced pathogenicity exhibited by the African genotype ZIKV
in human cells in vitro was correlated with the induction of early cell death and a strong antiviral
response [41,48,70,71,75], which explains the low amount of infectious viral particles produced in
vertebrate cells in our study.
African ZIKV strains are more virulent in mosquito cells [76]. This observation is supported by
our assessment of replication efficiency in a mosquito cell line (PFU/mL/Particles), shown in Figure 4.
However, cell-specific phenotypic differences observed between African ZIKV strains used in
our study might be related to the intrinsic properties of the African ZIKV strains, their species origin
or differential susceptibility to ZIKV infection for the cell lines used in our study [77–79]. Indeed,
mosquito strains ArD157995*E/NS5, ArD165522, ArD132912 and ArD128000*E/NS5 replicated more
efficiently in the mosquito cell line, while the human strain HD78788*E and the monkey strain MR766
showed higher replication in the vertebrate cell line. It is of note that the prototype ancestral ZIKV
strain MR766 replicated significantly more slowly. At least three MR766 strains exist with genetic
differences [80]. Our results indicate that strain MR766, which is used in the majority of ZIKV research
studies, cannot be considered as a reference, as it shows quite atypical ZIKV replication in both
vertebrate and mosquito cells.
Like other RNA viruses cycling between arthropod vector and mammal hosts, it was previously
found that the majority of codon sites in E and NS5 proteins of ZIKV undergo purifying
selection [17,51,81]. Nevertheless, some significant diversifying sites exist in the genome of the
African genotype ZIKV, such as recombination sites in E and NS5 proteins and the N-glycosylation
motif (NDT) at codon positions 154–156 of the E protein, which plays a crucial role in the replication
and virulence of flaviviruses [17,51,52,82,83]. Although recombination could not be associated
with one specific replication profile of African ZIKV strains in our study, the significant replication
difference between strains ArD128000*E/NS5 and HD78788*E, particularly in mosquito cells, points to
the detrimental impact of recombination in the NS5 protein on virulence and viral infectivity. The effect
of recombination on replication efficiency and virulence of ZIKV has long been suspected based on
phylogenetic studies [17,84,85]. The recombinant strain ArD128000*E/NS5, which replicated efficiently
in mosquito cells but exhibited no production of infectious particles in the vertebrate cell line over
146 hpi, indicated that recombination has an effect on host tropism.
In contrast to a previous in vivo study demonstrating that complete deletion—as observed in
most of the African ZIKV strains—or single amino acid substitution in the NDT motif cause less
infectivity [86], our study shows that the NDI motif at codon position 156 of the E protein is an
important determinant of the virulence and replication of African ZIKV strains in vertebrate cells.
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The recombination and N-glycosylation may lead to potential future adaptation and pathogenicity
of the African genotype ZIKV, and the biological and genetic characteristics of new isolates need to be
continuously monitored.
However, considering functional differences between in vitro and in vivo systems in terms of
physical barriers and antiviral responses, the fitness of African ZIKV strains with a NDI motif on
the E protein should be studied in vivo, since many other amino acid substitutions contributing
to ZIKV pathogenicity have been previously identified [87–89]. Enhanced infectivity of ZIKV in
the Aedes aegypti mosquito vector has been correlated with the signature A188V mutation in NS1,
which potentially facilitates transmission, and therefore, contributed to the spread of the virus from
Asia to the Americas [88,89].
In contrast to faster in vitro replication of African YFV in mosquito cells, the African ZIKV strains
exhibited more efficient replication, yielding more infectious particles. In contrast to YFV, which has a
long history of human infection in Africa [42,90], the African genotype ZIKV currently appears to be
maintained through a sylvatic cycle, and human infections still appear to be rare. However, our own
serological data from active surveillance of arboviruses in Senegal indicate that asymptomatic ZIKV
infections may be more widespread than assumed [91]. If confirmed, asymptomatic or unnoticed
infection could be an alternative explanation for the higher CAI values for the human genome of the
African genotype ZIKV.
In summary African genotype ZIKV isolates replicate more efficiently in mosquito cells than
in vertebrate cells. Their CAI indices, however, indicate a higher adaptation to vertebrates than
observed for Asian genotype ZIKV, which may reflect efficient sylvatic transmission cycles but possibly
also asymptomatic transmission in a peri-urban cycle. An analysis of the growth characteristics of
individual African genotype ZIKV strains revealed that strain MR766 is not suitable as a reference strain,
while recombinant strain ArD128000*E/NS5 may be a good model for use studies on the mechanism of
host tropism.
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